Compared with that in BC patients at stages I, II, and III, the CD4+AC in BC patients at stage IV decreased most strikingly (P < 0.001), which was followed by stage III (P < 0.01), stage II (P < 0.01), and stage I (P < 0.001) (Figure 2(b)). The gene discussed is CD4; the disease is breast cancer.